FDA Approves Unknown Drug — STRIDES PHARMA INTL
Strides Pharma International announced this week that its Abbreviated New Drug Application No. ANDA200812 had been approved by the FDA, paving the way for the introduction of a new…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Strides Pharma International announced this week that its Abbreviated New Drug Application No. ANDA200812 had been approved by the FDA, paving the way for the introduction of a new…
# FDA Approves Fresenius Kabi's Generic Meropenem Injectable Fresenius Kabi USA, LLC received FDA approval for its generic meropenem intravenous formulation, expanding the competi…
Rising Enterprises' FDA approval for the generic pharmaceutical product identified by ANDA200824 on October 18, 2011, is expected to introduce substantial price competition to the …
Unichem Pharmaceuticals (USA), Inc. announced the FDA approval of its oral LAMOTRIGINE generic formulation, a milestone that positions the company to compete for market share withi…
Sagent Pharmaceuticals has received FDA approval for the generic intramuscular injection of clindamycin phosphate, expanding its portfolio of branded generics. This approval streng…
NEW YORK (Thomson Financial) - Lupin Pharmaceuticals Inc. announced Thursday that the FDA has approved its generic version of mefenamic acid tablets, potentially expanding access t…
# FDA Approves SpecGx LLC's Generic Morphine Sulfate Oral Formulation SpecGx LLC has received FDA approval for its generic morphine sulfate oral formulation (ANDA202348), expandin…
# FDA Approves Janssen Pharmaceuticals' XARELTO (Rivaroxaban) Oral Anticoagulant Janssen Pharmaceuticals, Inc. received FDA approval for XARELTO (rivaroxaban), an oral anticoagula…
Rising Pharma Holdings, Inc. received FDA approval on June 8, 2011, for its ANDA091604 application to market the generic version of RAMIPRIL, an oral antihypertensive. This approva…
The FDA’s approval of a generic pharmaceutical from SANDOZ is poised to strengthen the company’s market presence and drive revenue growth, however, the specific therapeutics involv…
On March 22, 2011, Actavis Labs Fl Inc received FDA approval for ANDA090084, a generic drug anticipated to drive incremental sales in the specific therapeutic market while offering…
# FDA Approves Bayer's Gadavist (Gadobutrol) for MRI Contrast Imaging Bayer HealthCare Pharmaceuticals Inc. received FDA approval for Gadavist (gadobutrol), an intravenous contras…
Teva Pharmaceutical Industries received FDA approval on Thursday for Nifedipine Extended Release Tablets, extending its reach within the cardiovascular generic market.
SpecGx LLC announced the FDA approval of the Fentanyl Transdermal ANDA (App # ANDA077154) on February 9th, potentially expanding generic competition for the potent opioid pain patc…
Senores Pharma has secured FDA approval for its Abbreviated New Drug Application (ANDA090404), a pivotal development expected to bolster the company's commercial prospects and driv…
# FDA Approves GE Healthcare's DaTscan for Parkinson's Disease Diagnosis GE Healthcare's Medi-Physics division received FDA approval for DaTscan (ioflupane I-123), a diagnostic im…
# FDA Approves Alembic Pharmaceuticals' Generic Lamotrigine Alembic Pharmaceuticals Limited has received FDA approval for its generic lamotrigine oral formulation, expanding the c…
# FDA Approval Newswire Rising Pharmaceuticals received FDA approval for a new generic drug formulation (ANDA090431) on December 28, 2010, positioning the company to capture marke…
# FDA Approves Amneal Pharmaceuticals' Generic Oxymorphone Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic oxymorphone hydrochloride ora…
GENUS LIFESCIENCES received U.S. approval on Oct. 20 for NDA200534, a drug application; this regulatory milestone positions the company to potentially expand its market footprint p…